Joshua Veatch, MD, PhD
Joshua Veatch, MD, PhD, has always been drawn to science. He ultimately decided to study medicine and make a career out of it because of the meaningful relationships physicians are able to have with their patients. "I am both excited about the potential for developing new and better treatments for cancer, and am drawn to cancer care because of the depth of the relationships that can be formed with patients while they are going through something so hard and significant," he says. For Dr. Veatch, not only does he see patients in clinic at Seattle Cancer Care Alliance, but he is also involved in clinical research. He currently works with Dr. Stanley Riddell in the clinical research division at the Fred Hutch, working to develop new immune therapies to help patients with melanoma. In one project, they are developing a new type of cancer vaccine targeted at the mutations specific to a patient's cancer, in order to strengthen T-cell responses to fight the cancer. "We are also developing a new T-cell treatment for patients with the BRAF mutation," he says. "I hope that combinations of different immune therapies enable more patients with cancer to have lasting remissions, and that is a goal I am working towards in the lab and in the clinic,” Dr. Veatch says. Outside of work, Dr. Veatch enjoys rowing, hiking and cooking with his wife, son and daughter.
Specialty: Medical Oncology
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.